Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
13.41
5.42 (67.83%)
At close: Jun 04, 2025, 3:59 PM
13.39
-0.15%
After-hours: Jun 04, 2025, 07:59 PM EDT
67.83% (1D)
| Bid | 13.09 |
| Market Cap | 210.99M |
| Revenue (ttm) | 65K |
| Net Income (ttm) | -334.52M |
| EPS (ttm) | -25 |
| PE Ratio (ttm) | -0.54 |
| Forward PE | -11.87 |
| Analyst | Hold |
| Ask | 13.75 |
| Volume | 1,641,292 |
| Avg. Volume (20D) | 43,485 |
| Open | 8.02 |
| Previous Close | 7.99 |
| Day's Range | 7.78 - 13.76 |
| 52-Week Range | 7.65 - 53.90 |
| Beta | -0.27 |
About LYEL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYEL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LYEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+19.35%
Lyell Immunopharma shares are trading higher. The ...
Unlock content with
Pro Subscription
7 months ago
-5.22%
Lyell Immunopharma shares are trading higher after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.
